Corrigendum to “Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia”

• Scott McPherson,
• Getinet Tafese,
• Temesgen Tafese,
• Sinknesh Wolde Behaksra,
• Hiwot Solomon,
• Birhanu Oljira,
• Hirpa Miecha,
• Kaleab A. Debebe,
• Biruck Kebede,
• Teshome Gebre,
• Fikreab Kebede,
• Fikre Seife,
• Fentahun Tadesse,
• Belete Mammo,
• Abraham Aseffa,
• Anthony W. Solomon,
• David C.W. Mabey,
• Michael Marks,
• Endalamaw Gadisa

Affiliations

Scott McPherson

Faculty of Infectious and Tropical Diseases, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; RTI International, Research Triangle Park, NC, USA

Getinet Tafese

Armauer Hansen Research Institute, Addis Ababa, Ethiopia

Temesgen Tafese

Armauer Hansen Research Institute, Addis Ababa, Ethiopia

Sinknesh Wolde Behaksra

Armauer Hansen Research Institute, Addis Ababa, Ethiopia

Hiwot Solomon

Ministry of Health, Addis Ababa, Ethiopia

Birhanu Oljira

Oromia Regional Health Bureau, Addis Ababa, Ethiopia

Hirpa Miecha

Oromia Regional Health Bureau, Addis Ababa, Ethiopia

Kaleab A. Debebe

Armauer Hansen Research Institute, Addis Ababa, Ethiopia

Biruck Kebede

RTI International, Research Triangle Park, NC, USA

Teshome Gebre

International Trachoma Initiative, Decatur, GA, USA

Fikreab Kebede

Ministry of Health, Addis Ababa, Ethiopia

Fikre Seife

Ministry of Health, Addis Ababa, Ethiopia

Fentahun Tadesse

Ministry of Health, Addis Ababa, Ethiopia

Belete Mammo

RTI International, Research Triangle Park, NC, USA

Abraham Aseffa

Armauer Hansen Research Institute, Addis Ababa, Ethiopia

Anthony W. Solomon

Faculty of Infectious and Tropical Diseases, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland

David C.W. Mabey

Faculty of Infectious and Tropical Diseases, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK

Michael Marks

Faculty of Infectious and Tropical Diseases, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Hospital for Tropical Diseases, University College London Hospital, London, UK; Division of Infection and Immunity, University College London, London, UK; Corresponding author. Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Endalamaw Gadisa

Armauer Hansen Research Institute, Addis Ababa, Ethiopia